90 related articles for article (PubMed ID: 19893993)
21. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
[TBL] [Abstract][Full Text] [Related]
22. Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects.
Okabe TA; Shimada K; Hattori M; Murayama T; Yokode M; Kita T; Kishimoto C
Cardiovasc Res; 2007 Jun; 74(3):537-45. PubMed ID: 17374527
[TBL] [Abstract][Full Text] [Related]
23. Effects of rapamycin on the arterial inflammatory response in atherosclerotic plaques in Apo-E knockout mice.
Naoum JJ; Woodside KJ; Zhang S; Rychahou PG; Hunter GC
Transplant Proc; 2005 May; 37(4):1880-4. PubMed ID: 15919492
[TBL] [Abstract][Full Text] [Related]
24. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
[TBL] [Abstract][Full Text] [Related]
25. 17β-estradiol induces vasorelaxation by stimulating endothelial hydrogen sulfide release.
Zhou K; Gao Q; Zheng S; Pan S; Li P; Suo K; Simoncini T; Wang T; Fu X
Mol Hum Reprod; 2013 Mar; 19(3):169-76. PubMed ID: 23041593
[TBL] [Abstract][Full Text] [Related]
26. Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.
Zhao LY; Li J; Yuan F; Li M; Zhang Q; Huang YY; Pang JY; Zhang B; Sun FY; Sun HS; Li Q; Cao L; Xie Y; Lin YC; Liu J; Tan HM; Wang GL
Mar Drugs; 2015 Apr; 13(4):2306-26. PubMed ID: 25874925
[TBL] [Abstract][Full Text] [Related]
27. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
Desai A; Zhao Y; Warren JS
Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
[TBL] [Abstract][Full Text] [Related]
28. Arginase inhibition by piceatannol-3'-O-β-D-glucopyranoside improves endothelial dysfunction via activation of endothelial nitric oxide synthase in ApoE-null mice fed a high-cholesterol diet.
Woo A; Shin W; Cuong TD; Min B; Lee JH; Jeon BH; Ryoo S
Int J Mol Med; 2013 Apr; 31(4):803-10. PubMed ID: 23443634
[TBL] [Abstract][Full Text] [Related]
29. Intact endothelium-dependent dilation and conducted responses in resistance vessels of hypercholesterolemic mice in vivo.
Wölfle SE; de Wit C
J Vasc Res; 2005; 42(6):475-82. PubMed ID: 16155363
[TBL] [Abstract][Full Text] [Related]
30. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
[TBL] [Abstract][Full Text] [Related]
31. Posttransplantation therapeutic rapamycin concentration protects nitric oxide-related vascular endothelial function: comparative effects in rat thoracic aorta and coronary endothelial cell culture.
Parlar A; Can C; Erol A; Ulker S
Transplant Proc; 2010 Jun; 42(5):1923-30. PubMed ID: 20620549
[TBL] [Abstract][Full Text] [Related]
32. Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice.
Guo Y; Zhang C; Du X; Nair U; Yoo TJ
Hear Res; 2005 Oct; 208(1-2):54-67. PubMed ID: 16051453
[TBL] [Abstract][Full Text] [Related]
33. Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice.
Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Vascul Pharmacol; 2016 Apr; 79():16-23. PubMed ID: 26277250
[TBL] [Abstract][Full Text] [Related]
34. Postischemic endothelium-dependent vascular reactivity is preserved in adhesion molecule-deficient mice.
Banda MA; Lefer DJ; Granger DN
Am J Physiol; 1997 Dec; 273(6):H2721-5. PubMed ID: 9435608
[TBL] [Abstract][Full Text] [Related]
35. In utero arsenic exposure induces early onset of atherosclerosis in ApoE-/- mice.
Srivastava S; D'Souza SE; Sen U; States JC
Reprod Toxicol; 2007; 23(3):449-56. PubMed ID: 17317095
[TBL] [Abstract][Full Text] [Related]
36. Anti-atherosclerotic effects of serelaxin in apolipoprotein E-deficient mice.
Tiyerili V; Beiert T; Schatten H; Camara B; Jehle J; Schrickel JW; Nickenig G; Andrié RP
Atherosclerosis; 2016 Aug; 251():430-437. PubMed ID: 27341752
[TBL] [Abstract][Full Text] [Related]
37. Calcium channel blocker inhibits Western-type diet-evoked atherosclerosis development in ApoE-deficient mice.
Kyselovic J; Martinka P; Batova Z; Gazova A; Godfraind T
J Pharmacol Exp Ther; 2005 Oct; 315(1):320-8. PubMed ID: 16020630
[TBL] [Abstract][Full Text] [Related]
38. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model.
Sun Q; Wang A; Jin X; Natanzon A; Duquaine D; Brook RD; Aguinaldo JG; Fayad ZA; Fuster V; Lippmann M; Chen LC; Rajagopalan S
JAMA; 2005 Dec; 294(23):3003-10. PubMed ID: 16414948
[TBL] [Abstract][Full Text] [Related]
39. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
[TBL] [Abstract][Full Text] [Related]
40. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
